Mechanism of Action
The molecular effects of the drug are mediated through three primary pathways:
- Adenosine receptor blockade: caffeine is a competitive antagonist of adenosine. By eliminating its inhibitory influence (cellular hyperpolarization), the drug activates CNS neurons.
- Phosphodiesterase (PDE) inhibition: slowing the degradation of cAMP leads to its accumulation in brain and myocardial tissues, which enhances metabolic processes.
- Effects on intracellular calcium: modulation of $Ca^{2+}$ ion levels within cells.
Pharmacological Effects
The drug stimulates mental and physical activity, eliminating drowsiness and fatigue. Its hemodynamic effects involve stimulation of the vasomotor center: in hypotension, caffeine raises blood pressure, whereas at normal blood pressure, it has virtually no effect. Additionally, caffeine potentiates the action of non-narcotic analgesics, making it a common component in combination medications (e.g., Citramon).
Indications for Use
Caffeine-sodium benzoate is prescribed for conditions accompanied by CNS depression, drowsiness, and hypotensive states. In combination therapy, it is used for migraines (combined with ergot alkaloids) and as a component of analgesic formulations.
Side Effects and Contraindications
Main side effects include psychomotor agitation, insomnia, tachycardia, arrhythmias, and dyspeptic symptoms (nausea, vomiting). Long-term use may lead to dependence (theism).
Contraindications: severe arterial hypertension, atherosclerosis, glaucoma, and insomnia.
Pharmacokinetics and Administration Notes
Caffeine is a substrate for the CYP1A2 isoenzyme. Its metabolism depends on diet and environmental factors (e.g., smoking induces this enzyme, accelerating caffeine clearance). The drug is excreted in breast milk. It is important to consider that caffeine is a weak base; therefore, urinary acidification accelerates its excretion and diminishes its pharmacological action.